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Inflammation and macrophage foam cells are char-
acteristic features of atherosclerotic lesions, but
the mechanisms linking cholesterol accumulation to
inflammation and LXR-dependent response path-
ways are poorly understood. To investigate this rela-
tionship, we utilized lipidomic and transcriptomic
methods to evaluate the effect of diet and LDL
receptor genotype on macrophage foam cell forma-
tion within the peritoneal cavities of mice. Foam cell
formation was associated with significant changes
in hundreds of lipid species and unexpected
suppression, rather than activation, of inflammatory
gene expression. We provide evidence that regu-
lated accumulation of desmosterol underlies many
of the homeostatic responses, including activation
of LXR target genes, inhibition of SREBP target
genes, selective reprogramming of fatty acid metab-
olism, and suppression of inflammatory-response
genes, observed in macrophage foam cells. These
observations suggest that macrophage activation
in atherosclerotic lesions results from extrinsic,
proinflammatory signals generated within the artery
wall that suppress homeostatic and anti-inflamma-
tory functions of desmosterol.138 Cell 151, 138–152, September 28, 2012 ª2012 Elsevier Inc.INTRODUCTION
Macrophage foam cells are characterized bymassive accumula-
tion of lipid and contribute to all phases of atherosclerosis,
ranging from the initial development of fatty streaks to the
rupture of unstable plaques (Glass and Witztum, 2001; Rocha
and Libby, 2009). Macrophages within atherosclerotic lesions
are thought to acquire the foam cell phenotype through the
constitutive uptake and degradation of native and modified lipo-
proteins via scavenger receptors and micropinocytosis (Gold-
stein et al., 1979; Krieger and Herz, 1994; Miller et al., 2003).
Excess cholesterol delivered to the macrophage by these path-
ways must be either exported to extracellular acceptors via
cholesterol efflux pathways or esterified for storage in cyto-
plasmic lipid droplets in order to prevent the cytotoxic effects
associated with elevated free cholesterol within the endoplasmic
reticulum (Tabas, 2010).
Many lines of evidence support the concept that inflammation
plays a key role in the initiation, progression, and clinical compli-
cations of atherosclerosis (Glass and Witztum, 2001; Hansson
et al., 2006; Rocha and Libby, 2009; Ross, 1993). Chemokines
produced in response to inflammatory signals promote recruit-
ment of monocytes/macrophages and other immune cells into
the artery wall. These cells in turn secrete numerous factors,
including cytokines, reactive oxygen species, and additional
chemokines, that amplify inflammation and promote lesion
development (Charo and Taubman, 2004; Hansson et al.,
2006). Production of matrix metalloproteinases by macrophage
foam cells in advanced lesions is thought to contribute to weak-
ening of the fibrous cap and an increased risk of plaque rupture
and acute myocardial infarction (Galis et al., 1995; Hansson
et al., 2006; Rocha and Libby, 2009).
A relationship also exists between circulating levels of
low-density lipoprotein (LDL) cholesterol and inflammatory
responses that promote atherosclerosis. Elevated LDL choles-
terol levels are strongly correlated with risk for the development
of clinically significant atherosclerosis in humans and with
circulating markers of inflammation, such as C reactive protein
(Blake and Ridker, 2003; Hansson et al., 2006). Similarly, animal
models of atherosclerosis that are driven by genetic and/or
dietary manipulations resulting in markedly elevated plasma
cholesterol levels promote rapid lesion development and the
attendant expression of inflammatory mediators (Getz and
Reardon, 2006).
Despite these clear relationships, the mechanisms by which
hypercholesterolemia induces the inflammatory response asso-
ciated with atherosclerotic lesions remain poorly understood.
Elevated levels of circulating LDL are thought to lead to
increased rates of formation of oxidized LDL (oxLDL) and other
modified forms of LDL in the artery wall (Steinberg, 2009). In
addition to being a ligand for macrophage scavenger receptors,
oxLDL contains numerous bioactive lipid species that can act on
several cell types within the artery wall to induce the expression
of proinflammatory mediators, including cytokines, chemokines,
and adhesion molecules (Steinberg, 2009). OxLDL and other
modified forms of LDL have been shown to exert inflammatory
effects through several different pattern recognition receptors,
including Toll-like receptors (TLR) (Choi et al., 2009; Chou
et al., 2008; Xu et al., 2001). Increasing evidence supports roles
for TLR 2 and 4 in promoting inflammation and atherosclerosis in
mouse models and human lesions (Michelsen et al., 2004;
Monaco et al., 2009; Mullick et al., 2008). In addition, macro-
phage uptake of cholesterol crystals has been shown to result
in activation of the inflammasome (Duewell et al., 2010). Collec-
tively, these findings suggest that hypercholesterolemia is
directly linked to both foam cell formation and inflammation.
To further investigate the relationship between hypercholes-
terolemia, foam cell formation, and inflammation, we performed
lipidomic and transcriptomic analyses of elicited peritoneal
macrophages in wild-type (WT) or LDL receptor knockout
(LDLR KO) mice fed either a normal-cholesterol, normal-fat
(NCNF) diet or a high-cholesterol, high-fat (HCHF) ‘‘Western’’
style diet. The combination of the LDLR KO genotype and the
HCHF diet results in the formation of macrophage foam cells in
the elicited peritoneal macrophage population (Li et al., 2004).
Analysis of macrophages from the above four experimental
groups revealed massive reprogramming of the lipidome in
response to both diet and genotype. These studies confirmed
and extended prior knowledge regarding the roles of SREBP
and LXR signaling in cholesterol and fatty acid homeostasis.
Unexpectedly, peritoneal macrophage foam cells exhibited
a strongly ‘‘deactivated’’ phenotype, with marked suppression
of proinflammatory mediators that are normally characteristic
of the inflammatory responses associated with atherosclerotic
lesions. Many of these changes in gene expression and lipid
metabolism appear to be related to the paradoxical accumula-tion of high levels of desmosterol, the last intermediate in the
Bloch pathway of cholesterol biosynthesis.
RESULTS
Overview of the Elicited Macrophage Foam Cell
Lipidome and Transcriptome
WT or LDLR KOmice were fed either a NCNF diet or a HCHF diet
for 12 weeks to establish four experimental groups (WT-NCNF
diet, WT-HCHF diet, KO-NCNF diet, and KO-HCHF diet). As
expected, the combination of the HCHF diet and LDLR KO
genotype resulted in a synergistic effect on serum lipid levels
(Figure 1A). Elicited peritoneal macrophages (92%–96% F4/80-
positive) were immediately prepared for analysis, thereby
preserving in vivo gene expression and lipid profiles. Macro-
phages derived from LDLRKOmice fed theHCHF diet contained
nearly 4-fold more total cholesterol than cells from WT mice fed
the same diet (Figure 1B). Quantitative analysis of 245 lipid
species revealed significant changes in nearly all major lipid
classes (Figure 1C). Using a two-way ANOVA model, we found
that 176 (72%) of the lipids analyzed were significantly affected
by the HCHF diet, 133 (54%) by the LDLR KO genotype, and
114 (46%) by interactions between the HCHF diet and LDLR
KO genotype (Table S1A available online). Many of the observed
interactions (60%) were synergistic.
Parallel analysis of the macrophage transcriptome also
demonstrated a synergistic effect of LDLR genotype and diet
on gene expression (Figures 1D and 1E; Tables S1B–S1E). Using
a cut-off threshold of 1.5-fold change and a false discovery rate
(FDR) threshold of 0.05, we observed that the HCHF diet resulted
in significantly more gene expression changes in LDLR KO mice
than in WTmice. We also observed that more genes were down-
regulated than upregulated by the HCHF diet in both genotypes.
Genes with functions related to blood vessel development, lipid
transport, and extracellular matrix organization were over-repre-
sented in the upregulated gene sets identified in LDLR KO
macrophages (Figure 1D; Tables S1B–S1E). As expected, genes
associated with sterol biosynthesis were enriched in the set of
downregulated genes. Unexpectedly, genes with functional
annotations linked to inflammation, immunity, and defense
response were the most highly over-represented genes in the
downregulated gene set (Figure 1E; Tables S1B–S1E).
Alterations of Cholesterol Homeostasis in Macrophage
Foam Cells
Cholesterol biosynthesis is mediated by a biochemical
pathway, starting from acetyl-CoA (Figure 2A), whose encoding
genes are primarily regulated by the transcription factor
SREBP2. Elevated levels of cholesterol and certain oxysterols
inhibit the proteolytic processing of SREBP2 (encoded by
Srebf2), thereby reducing levels of the active transcription
factor in the nucleus and resulting in downregulation of most
of the enzymes in the biosynthetic pathway (Goldstein et al.,
1979). Transcriptomic analysis confirmed that many enzymes
of cholesterol synthesis, including Hmgcs1, Hmgcr, Lss, and
Dhcr24, were downregulated by the HCHF diet, especially in
LDLR KO mice (Figure 2B), with Dhcr24 being the most
suppressed transcript among the entire set of transcriptsCell 151, 138–152, September 28, 2012 ª2012 Elsevier Inc. 139
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Figure 1. Overview of Global Effects of Diet
and LDLR KO Genotype on the Lipidome
and Transcriptome of Elicited Peritoneal
Macrophages
(A) Serum cholesterol and triglyceride levels in
elicited peritoneal macrophages fromWT or LDLR
KO mice fed either NCNF or HCHF diet. HCHF
versus NCNF: ***p < 0.001, **p < 0.01, *p < 0.05.
KO versus WT: p < 0.001, p < 0.01, +p < 0.05.
Error bars represent standard error of the mean
(SEM). n = 5.
(B) Total cellular cholesteryl esters in peritoneal
macrophages derived from WT or LDLR KO mice
fed either NCNF or HCHF diet. p value notations
are the same as in (A) (n = 9).
(C) Heatmap of lipid changes in lipid categories.
Log2 of ratio values are used in each entry.
Red shading indicates upregulation, and green
indicates downregulation. For the subclasses
under glycerophospholipids, the abbreviations
are as follows: PG (glycerophosphoglycerols),
PE (glycerophosphoethanolamines), PC (glycer-
ophosphocholines), PI (glycerophosphoinositols),
PA (phosphatidic acids), and PS (glycer-
ophosphoserines).
(D) Venn diagram of upregulated genes and their
overlap by HCHF diet > 1.53 in the transcriptome
of WT and LDLR KO macrophages, and p values
for selected gene ontology (GO) terms.
(E) Venn diagram of downregulated genes and
their overlap by HCHF diet > 1.53 in the tran-
scriptome of WT and LDLR KOmacrophages, and
p values for selected GO terms.evaluated. LXRs provide a feedforward system for regulation of
cholesterol homeostasis through activation of genes involved in
cholesterol efflux, such as Abca1 and Abcg1 (Kennedy et al.,
2001; Venkateswaran et al., 2000), and induction of the Idol
gene that promotes degradation of the LDL receptor (Zelcer
et al., 2009). These genes were significantly upregulated in
macrophages elicited from mice fed the HCHF diet, especially
from LDLR KO mice, as expected (Figure 2B).
The transcriptional activities of LXRs are positively regulated
by specific oxysterols and sterols that include 24S-hydroxycho-
lesterol (24-OHC), 25-hydroxycholesterol (25-OHC), 27-hydrox-
ycholesterol (27-OHC), 24,25-epoxycholesterol (24,25-EC), and
desmosterol (Yang et al., 2006; Chen et al., 2007; Janowski
et al., 1996). Genetic studies have demonstrated that 24-
OHC, 25-OHC, and 27-OHC are major oxysterols that regulate
LXR activity in liver (Chen et al., 2007), but the oxysterol species
that regulate LXRs in the context of macrophage foam cell
formation have not been established. Surprisingly, desmosterol140 Cell 151, 138–152, September 28, 2012 ª2012 Elsevier Inc.was by far the major LXR ligand to accu-
mulate in peritoneal macrophage foam
cells (Figure 2C). Significant increases
in 24S-OHC, 25-OHC, and 27-OHC
were also observed (Figures 2C and
S2A), but the absolute amounts of these
oxysterols were approximately 50-fold
lower than the amount of desmosterol.Furthermore, genes encoding enzymes required for synthesis
of 24-OHC, 25-OHC, and 27-OHC (Cyp46a1, Ch25h, and
Cp27a1, respectively) were unchanged or downregulated in
macrophage foam cells (Figure 2B). Based on the relative affin-
ities of desmosterol, 24S-OHC, 25-OHC, and 27-OHC for LXRs
(Yang et al., 2006) and the ability of desmosterol to suppress
SREBP processing, these findings suggest that desmosterol
is the dominant bioactive sterol in peritoneal macrophage
foam cells.
To examine the potential relevance of this finding to macro-
phage foam cells in atherosclerotic lesions, human atheroscle-
rotic lesions obtained during clinically indicated atherectomy of
the lower extremities from three symptomatic patients with
lifestyles limiting claudication were analyzed for sterols and
oxysterols. This analysis indicated that relative levels of desmos-
terol significantly exceeded those of other known LXR ligands
(Figures 2D and S1B), similar to the pattern observed in perito-
neal macrophage foam cells.
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Figure 2. Foam Cell Formation Is Associated with Increased Cellular Content of Desmosterol
(A) A simplified scheme of cholesterol and oxysterol biosynthetic pathways. Selected lipid intermediates are labeled in green boxes, and important enzymes are
labeled in yellow ellipses. Lipid species shown in blue boxes are LXR agonists.
(B) Effect of the HCHF diet on levels of mRNA transcripts of proteins involved in cholesterol homeostasis fromWT and LDLR KOmacrophages, as determined by
microarray analysis. ***p < 0.001, **p < 0.01, *p < 0.05 (n = 5).
(C) Cellular levels of selected endogenous LXR ligands. p value notations are the same as in Figure 1A (n = 9).
(D) Levels of selected LXR ligands in human atherosclerotic lesions. Ligand levels per sample were normalized to cholestanol. Ligand versus desmosterol:
***p < 0.001, **p < 0.01, *p < 0.05.
Error bars represent SEM, and n = 3 unless otherwise indicated. See also Figure S1.
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Altered Fatty Acid Metabolism in Macrophage
Foam Cells
The HCHF diet induced numerous changes in saturated, mono-
unsaturated, and polyunsaturated free fatty acids (FFAs), partic-
ularly in macrophages elicited from LDLR KO mice (Figure 1C;
Table S1A). Among the most prominent of these changes were
increases in 9Z-palmitoleic acid, recently suggested to be a
‘‘lipokine’’ capable of improving insulin sensitivity when injected
intravenously in mice (Cao et al., 2008), and oleic acid, which is
the dominant FFA incorporated into cholesterol esters (CE)
(Figure 3A; Table S1A). Molecular species containing these fatty
acids were also markedly increased in the cellular phospholipid
pool, almost exclusively in the glycerophosphoglycerol (PG)
fraction (Figures 1C and 3A).
Metabolic steps involved in the biosynthesis of palmitic, stea-
ric, 9Z-palmitoleic, and oleic acids are indicated in Figure 3B,
and the effects of diet on the expression of genes encoding
the enzymes that catalyze these and other steps are indicated
in Figure 3C. The most notable changes were diet-induced
suppression of Fads1 and Fasn expression in macrophages
derived from LDLR KO animals and diet-induced increases in
expression of Acot1 and Scd2 in macrophages derived from
both WT and LDLR KO mice. The suppression of Fasn expres-
sion implies that there should be relatively little contribution of
endogenous biosynthesis to palmitic acid levels. Palmitic acid,
oleic acid, and stearic acid are major fatty acyl components of
triglycerides in the HCHF diet, suggesting that increases in these
macrophage FFAs are primarily due to hydrolysis of lipoprotein-
derived triglyceride; however, the relative increase in oleic acid is
significantly greater than that of palmitic acid, and 9Z-palmitoleic
acid is not a significant fatty acid in the HCHF diet. These
relationships suggest that the majority of 9Z-palmitoleic acid
and a fraction of oleic acid are derived from the conversion of
palmitic acid and stearic acid, respectively, due to upregulation
of Acot1/2 and Scd1/2.
Desmosterol Integrates LXR- and SREBP-Dependent
Gene Expression
In addition to cooperating with SREBP2 to regulate cholesterol
homeostasis, LXRs and SREBP1a and SREBP1c regulate fatty
acid metabolism (Chen et al., 2007), providing a potential
connection point at which desmosterol could integrate these
distinct pathways. SREBP1a and 1c are derived by transcription
from alternative promoters and preferentially drive the expres-
sion of genes involved in fatty acid biosynthesis, including
Fasn, Fads1, Fads2, Scd1, and Scd2. The SREBP1c promoter
is potently activated by synthetic LXR ligands (Repa et al.,
2000), but the physiological relevance of LXR activation of this
pathway in macrophages is unclear.
To investigate the ability of desmosterol to differentially
regulate expression of genes involved in cholesterol and fatty
acid metabolism through integration of LXR-dependent and
SREBP-dependentmechanisms, gene expression was analyzed
in elicited peritoneal macrophages treated with desmosterol, the
synthetic LXR agonist GW3965, or a combination of desmosterol
andGW3965. Due to the ability of desmosterol, but not GW3965,
to suppress SREBP processing, this experimental design allows
inferences to be made regarding the relative contributions of142 Cell 151, 138–152, September 28, 2012 ª2012 Elsevier Inc.direct activation of LXR target genes (i.e., activation by
GW3965 in the presence of desmosterol) and responses
mediated through secondary activation of SREBP1c (i.e.,
GW3965-induced expression that is suppressed by desmos-
terol). Consistent with this hypothesis, we observed the
expected desmosterol-specific suppression of the SREBP
target gene Dhcr24 (Figures 4A and S2A). Parallel chromatin
immunoprecipitation (ChIP) experiments confirmed a desmos-
terol-specific reduction of SREBP2 binding at the Dhcr24
sterol-response element (Figure 4B). Conversely, desmosterol
and GW3965 treatment resulted in a similar level of induction
of the LXR target gene Abcg1 (Figure 4A), with desmosterol ex-
erting these effects in a concentration- and LXR-dependent
manner (Figure S2A). Genes involved in fatty acid biosynthesis
exhibited more complex patterns of regulation. Fasn was selec-
tively activated by GW3965, and this induction was almost
completely abolished by cotreatment with desmosterol. This
result is consistent with GW3965 inducing SREBP1c expression,
which is required for Fasn activation. In contrast, Srebf1, Acsl4,
and Scd2 were strongly activated by GW3965 and less strongly
but significantly activated by desmosterol in a concentration-
and LXR-dependent manner (Figures 4A and S2A). Similar
patterns of regulation were observed in desmosterol-treated
human monocyte-derived macrophages (HMDMs) (Figure S2B).
Using a specific small interfering RNA (siRNA) to knock down
SREBP1 expression, we confirmed a requirement for SREBP1
for effects of GW3965 on expression of Scd2, Acsl4, and Fasn,
but not Abcg1, expression (Figures 4C and S2C). ChIP experi-
ments demonstrated significant increases in SREBP1 occu-
pancy of all target genes examined following treatment with
GW3965, exemplified by Scd2 and Fasn (Figure 4B). In contrast,
treatment of cells with desmosterol resulted in reduced SREBP1
occupancy at these genes. Further, desmosterol increased LXR
transcriptional activity as demonstrated by induction of lucif-
erase reporter constructs driven by either the Abca1 promoter
or an LXR enhancer element located 10 kb upstream of the
Scd2 promoter (Heinz et al., 2010) (Figure 4D). Consistent with
these findings, treatment of macrophages with desmosterol
led to increased cellular content of both SCD2 protein (Fig-
ure S2D) and its products oleic and 9Z-palmitoleic acid
(Figure 4E).
Desmosterol Is Generated in Response to Cholesterol
Loading
The accumulation of desmosterol in the context of foam cell
formation was surprising given the observed suppression of
the cholesterol biosynthetic pathway. To determine the effects
of cholesterol loading on LXR ligand synthesis, we incubated
cholesterol-starved peritoneal macrophages with cholesterol
delivered in ethanol and quantified sterols and oxysterols by
mass spectrometry. Unesterified desmosterol was by far the
dominant LXR ligand observed in these experiments, but total
levels were similar in cholesterol-starved (522 ± 62 pmol/106
cells) and cholesterol-loaded cells (482 ± 18 pmol/106 cells)
(Figure S3A). We therefore considered the possibility that an
increase in desmosterol arising from cholesterol accumulation
might be obscured in cholesterol-starved cells in which the
cholesterol biosynthetic pathway is induced. Consistent with
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ophosphoglycerols (PG) in peritoneal macro-
phages from WT and LDLR KO mice fed either
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Figure 5. Desmosterol Accumulation and
Function in Response to Cholesterol
Loading of Primary Macrophages In Vitro
(A) LC-MS analysis of the effect of cholesterol
loading of cholesterol-starved peritoneal macro-
phages on media content of desmosterol,
25-OHC, and 27-OHC.
(B) Effect of cholesterol loading on Abcg1, Dhcr24,
and Hmgcr expression in the peritoneal macro-
phages used for analysis in (A).
(C) Effect of cholesterol loading on expression of
Abca1, Abcg1, Scd2, and Dhcr24 in WT peritoneal
macrophages and TKO peritoneal macrophages
deficient for Cyp46a1, Ch25h, and Cyp27a1.
For (A)–(C), ***p < 0.001, **p < 0.01, *p < 0.05
versus control. n = 2.
(D) Effect of triparanol inhibition of DHCR24
enzyme activity on the indicated LXR and SREBP
target genes in WT and LXRa/b double knockout
(LXR DKO) peritoneal macrophages. ***p < 0.001
versus control. p < 0.001, p < 0.01 DKO
versus WT.
Error bars represent SD, and n = 3 unless other-
wise indicated. See also Figure S3.this possibility, macrophages cultured in the presence of 10%
serum (i.e., not cholesterol starved) exhibited a lower basal level
of free desmosterol (339 ± 6 pmol/106 cells) that increased (to
502 ± 44 pmol/106 cells, p < 0.05) upon cholesterol loading
(Figure S3A).
The observation that desmosterol was the major LXR ligand
in cholesterol-starved cells, in which LXR target genes are
suppressed, suggests that this intermediate is preferentially
utilized for cholesterol biosynthesis under these conditions andFigure 4. Desmosterol Coordinately Regulates LXR- and SREBP-Dependent Gene Expressio
Oleic Acid in Macrophages
(A) Quantitative PCR (qPCR) analysis of indicated mRNA transcripts in peritoneal macrophages treated with
(B) ChIP assay of SREBP at sterol-response elements that control the expression of theDhcr24, Scd2, Fasn, a
macrophages under control, GW3965, or desmosterol treatment (6 hr). n =2.
(C) Effect of Srebf1 knockdown on the expression of genes involved in cholesterol and fatty acid metabolism
desmosterol-treated, or GW3965-treated conditions. p < 0.001, p < 0.01, +p < 0.05 versus siCTL.
(D) Effect of GW3965 and desmosterol treatment on induction of indicated LXR reporter constructs in RAW
(E) LC-MS analysis of the effects of desmosterol on cellular contents of 9Z-palmitoleic and oleic acid in per
For (A), (B), (D), and (E), ***p < 0.001, **p < 0.01, *p < 0.05 versus control. Error bars represent standard deviat
also Figure S2.
Cell 151, 138–152, Senot accessible to LXRs. Unexpectedly,
treatment of cholesterol-starved macro-
phages with increasing concentrations of
free cholesterol, ranging from 0.3 mg/ml
to 30 mg/ml, resulted in a marked dose-
dependent increase in desmosterol in
the medium (Figure 5A). Concentrations
of 25-OHC and 27-OHC also increased
in the medium in response to cholesterol
loading, but at much lower levels (Fig-
ure 5A). Notably, expression levels of
LXR target genes, such as Abcg1 (Fig-
ure 5B), were closely correlated with des-
mosterol levels in the medium. Similarresults were obtained in cholesterol-loaded HMDMs (Figures
S3B and S3C).
To investigate whether the LXR pathway can respond to
cholesterol accumulation independently of oxysterol production,
cholesterol-loading experiments were performed to compare
WT macrophages and triple knockout (TKO) macrophages
derived from mice lacking the major enzymes responsible for
production of 24-OHC, 25-OHC, and 27-OHC (Cyp46a1,
Ch25h, and Cyp27a1). Basal expression levels of Abca1 andn and Induces Synthesis of Palmitoleic and
GW3965, desmosterol, or both.
ndHmgcr genes in cholesterol-depleted peritoneal
in peritoneal macrophages under lipid-depleted,
264.7 cells.
itoneal macrophages.
ion (SD), and n = 3 unless otherwise indicated.. See
ptember 28, 2012 ª2012 Elsevier Inc. 145
Figure 6. Desmosterol Inhibits Inflammatory Gene Expression
(A) TLR4 target genes are suppressed in macrophages derived from LDLR KO mice fed a HCHF diet. Relative expression of the 200 most highly induced TLR4
target genes in WT macrophages are plotted for LDLR KO macrophages under HCHF and NCNF diet conditions.
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Abcg1 were reduced in cholesterol-starved TKO macrophages
as compared to WT macrophages, consistent with 24S-OHC,
25-OHC, and/or 27-OHC playing roles in regulating basal LXR
activity under these conditions (Figure 5C). However, cholesterol
loading of TKO macrophages still resulted in a robust activation
of Abca1 and Abcg1 (Figure 5C), with the fold-change in gene
expression being similar to that of WT macrophages. As des-
mosterol is the only other significant LXR ligand produced in
response to cholesterol loading, these results provide genetic
evidence that this sterol activates the LXR program of gene
expression in response to excess cholesterol. Although choles-
terol loading strongly suppressed Dhcr24 expression in both WT
and TKO macrophages, this condition resulted in a further
increase in Scd2 expression (Figure 5C and S2D), consistent
with the ability of Scd2 to be positively regulated by an LXR-
dependent, SREBP1-independent mechanism (Figure S3D).
The cholesterol biosynthetic pathway bifurcates at lanosterol
(Figure 2A), with DHCR24 catalyzing the first step of the
Kandutch-Russell pathway (lanosterol to 24,25-dihydrolanos-
terol) and the last step of the Bloch pathway (desmosterol to
cholesterol). Thus, preferential downregulation of Dhcr24 would
be expected to result in accumulation of desmosterol as long as
the upstream steps of the cholesterol biosynthetic pathway
are not completely suppressed. Quantitative PCR analysis of
gene expression in the same cells used for sterol and oxysterol
analyses indicated that Dhcr24 and Hmgcr are both down-
regulated at between 1 and 3 mg/ml of added cholesterol (Fig-
ure 5B). However, Dhcr24 becomes profoundly repressed
(>95%), whereas Hmgcr messenger RNA (mRNA) remains
expressed at approximately 30% of the levels observed in
cholesterol-starved cells. Although additional posttranslational
mechanisms regulating enzymatic activity may also influence
desmosterol levels, the concentration-dependent changes in
Dhcr24 mRNA were in good agreement with the concentration-
dependent increases in media desmosterol and LXR target
gene activation (Figures 5A, 5B, S3B, and S3C).
Todeterminewhether reductionofDHCR24activity is sufficient
to activate LXRs, we inhibited the enzyme by treating macro-
phages with triparanol (Avigan et al., 1960) and then evaluated
LXR-dependent gene expression. Triparanol-mediated inhibition
of enzyme activity led to an LXR-dependent induction of target
genes (Figure 5D), consistent with the observation that triparanol
treatment increases desmosterol levels in Chinese hamster ovary
(CHO) cells (Yang et al., 2006). Similarly, siRNA-mediated reduc-
tion of Dhcr24 levels resulted in significant accumulation of des-
mosterol in macrophages (Figures S3E and S3F).(B) Relative expression levels of the 24most downregulated genes in LDLR KOma
highlighted in red. Results are plotted as log2-fold change. p < 0.001 (n = 9).
(C) Effect of cholesterol loading on KLA-induced expression of Cxcl10 and Cxcl9
(D) Effect of desmosterol treatment on KLA-induced expression of Cxcl9 and Cx
(E) Effect of cholesterol loading on KLA-induced expression of Cxcl9 and Cxcl10
(F) Effect of desmosterol treatment on KLA-induced expression of Cxcl9 and Cx
(G) Effect of triparanol inhibition of DHCR24 enzyme activity on the KLA responsive
(H) Effect of 9Z-palmitoleic acid (9Z-PO) treatment on KLA responses of Cxcl9 a
(I) Effect of knockdown of Scd2 (72 hr) on KLA responses of Cxcl9 and Cxcl10 g
(J) Effect of 9Z-palmitoleic acid (9Z-PO) treatment on KLA responses of Cxcl9 an
For (C)–(J), **p < 0.01, *p < 0.05 versus KLA or siCTL-KLA. Error bars represent S
refers to thioglycollate-elicited macrophages, and HMDM refers to HMDMs.FoamCell Formation and InflammatoryGeneExpression
Perhaps the most unexpected finding related to macrophage
foam cell formation in the peritoneal cavity was the broad
suppression of genes that are normally induced by proinflamma-
tory stimuli. Notably, a majority of the genes that are highly
induced (>4-fold at 6 hr) in macrophages by the TLR4-specific
agonist Kdo2 lipid A (KLA) (Raetz et al., 2006) were downregu-
lated in macrophage foam cells derived from LDLR KO mice
fed the HCHF diet (Figure 6A). The most strongly suppressed
inflammatory-response genes at an FDR < 0.05 are illustrated
in Figure 6B and include Il1b, Cxcl9, and Cxcl10. These
findings suggested that cholesterol accumulation suppressed,
rather than stimulated, signaling pathways responsible for the
activation of these genes in macrophages. Consistent with
this, cholesterol loading of thioglycollate-elicited macrophages
inhibited activation of a subset of TLR4-responsive genes,
exemplified by Cxcl9 and Cxcl10 (Figure 6C). In addition,
pretreatment of macrophages with desmosterol resulted in
a significant reduction of the KLA-mediated increases in expres-
sion of the Cxcl9 and Cxcl10 mRNAs (Figure 6D). The inhibitory
effects of cholesterol loading and desmosterol treatment were
also observed at the levels of the secreted proteins (Figure S4A).
Similar effects were observed in HMDMs (Figures 6E and 6F) and
for a significant subset of the TLR4-reponsive genes that were
suppressed by the HCHF diet in elicited LDLR KOmacrophages
(Figure S5B), indicating that exogenous desmosterol is capable
of recapitulating aspects of the deactivated phenotype exhibited
by macrophage foam cells formed in vivo. In addition to sup-
pressing TLR4-dependent gene expression, desmosterol also
inhibited activation of responses to tumor necrosis factor alpha
(TNF-a), Pam3 (TLR2 agonist), and poly(I:C) (TLR3 agonist) to
variable extents, exemplified by Cxcl10 (Figure S4B).
To investigate whether endogenously produced desmosterol
can exert an anti-inflammatory response, we treated macro-
phages with triparanol to inhibit DHCR24 enzyme activity or
used specific siRNAs to knock downDHCR24mRNA expression
(Figure S4C). Each of these perturbations that cause accumula-
tion of endogenous desmosterol resulted in reduced responsive-
ness ofCxcl9 andCxcl10 to KLA (Figures 6G and S4D). Similarly,
inhibition of DHCR24 enzyme activity in HMDMs led to reduced
responses of Cxcl9 and Cxcl10 to KLA (Figure S4E).
The finding of increased levels of 9Z-palmitoleic acid inmacro-
phage foam cells and the report that this fatty acid can function
as an insulin-sensitizing lipokine (Cao et al., 2008) led us to
directly evaluate the lipid’s effects on macrophage activation.
Overnight incubation of elicited peritoneal macrophages orcrophages frommice fed the HCHF versus NCNF diet. TLR4-responsive genes
genes in peritoneal macrophages.
cl10 genes in peritoneal macrophages.
genes in HMDMs.
cl10 genes in HMDMs.
ness ofCxcl9 andCxcl10 genes in peritonealmacrophages. See also Figure S4.
nd Cxcl10 genes in peritoneal macrophages.
enes in peritoneal macrophages. n = 2.
d Cxcl10 genes in HMDMs.
D, and n = 3 unless otherwise indicated. In all panels where indicated, TGEM
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HMDMs with 9Z-palmitoleic acid blunted activation of several
TLR4-inducible genes, including Cxcl9 and Cxcl10 (Figures 6H
and 6I). Conversely, siRNA knockdown of Scd2 (Figure S4F)
resulted in increased responses of these genes (Figure 6J).
To investigate mechanisms by which desmosterol inhibits
TLR4 signaling, we assessed the effect of desmosterol
treatment on luciferase reporter genes driven by the TLR4-
responsive iNOS promoter (Ricote et al., 1998), multimerized
NF-kB sites, or multimerized binding sites for the macrophage
lineage-determining factor PU.1. Desmosterol treatment in-
hibited KLA activation of the iNOS and NF-kB-driven promoters
but had no effect on expression of the PU.1-element-driven
promoter (Figure 7A). Although these results suggested that des-
mosterol inhibited NF-kB-dependent gene expression at the
level of transcription, ChIP experiments indicated that desmos-
terol treatment did not prevent binding of the p65 subunit of
NF-kB to target response elements (Figure S5A).
Previous studies have shown that LXRs can inhibit TLR4
signaling in macrophages by binding to and preventing the
removal of NCoR/histone-deacetylase corepressor complexes
at TLR4-responsive regulatory elements (Ghisletti et al., 2007).
This repression mechanism does not alter p65 binding but
prevents signal-dependent histone acetylation required for
gene activation. We therefore assessed the effect of desmos-
terol treatment on local acetylation status of histone H3 lysine
9/14 (H3K9/14Ac), a histone modification that is associated
with gene activation (Roh et al., 2007). Desmosterol inhibited
KLA-mediated H3K9/14 acetylation at regulatory elements of
theCxcl9 andCxcl10 genes (Figure 7B). In addition, desmosterol
treatment promoted recruitment of LXR to Cxcl9, Cxcl10, iNos,
and Il1b regulatory elements (Figure 7C), consistent with the
presence of NCoR at these sites under basal conditions (Barish
et al., 2012). Accordingly, desmosterol-mediated repression
of a number of KLA-responsive genes was compromised in
LXR DKO macrophages (Figure 7D). However, desmosterol
continued to exert partial repressive effects on inflammatory-
response genes even in LXR DKO macrophages (Figure 7D),
indicating additional LXR-independent mechanisms.
DISCUSSION
Desmosterol Integrates Feedforward and Feedback
Regulation of Cholesterol Homeostasis
Due to their normal physiological roles in phagocytosis of
apoptotic and necrotic cells, macrophages must both suppress
SREBP processing and upregulate LXR-dependent efflux mech-Figure 7. Desmosterol Inhibits Inflammatory Gene Expression by LXR
(A) Effect of desmosterol treatment on KLA induction of relative luciferase activit
(B) ChIP analysis of effect of desmosterol treatment on KLA-induced H3K9/14 ace
Cxcl10 genes in peritoneal macrophages. Negative control (Neg Ctl) refers to ge
(C) ChIP analysis of LXR recruitment to desmosterol-repressed loci of the Cxcl9
vehicle (Notx) or desmosterol for 6 hr. Relative enrichments are presented as %
(D) qPCR analysis of the effect of desmosterol treatment on KLA response ofCxcl
versus WT. Results are plotted as log2-fold change. Error bars represent SD, an
(E) Model for mechanisms by which foam cell formation induces desmosterol acc
suppression of inflammatory gene expression.
Error bars represent SD. See also Figure S5.anisms to maintain cholesterol homeostasis. Although free
cholesterol is a potent suppressor of SREBP processing by
binding to SCAP, it does not directly activate LXRs. The present
studies provide evidence that, rather than converting cholesterol
to an oxysterol, desmosterol (an intermediate in the cholesterol
biosynthetic pathway) is the dominant LXR ligand generated
during foam cell formation in vivo. Studies of the structural basis
for the ability of the dietary sterol stigmasterol to activate LXRs
led to the finding that desmosterol, although not previously
considered to be a physiologically important LXR ligand, is an
effective activator of LXR (Yang et al., 2006). Furthermore, these
studies demonstrated that desmosterol bound directly to LXRs,
induced recruitment of coactivators, and activated LXR target
genes in WT but not LXR KO cells. Although the binding affinity
of desmosterol for LXRs is about one-fifth that of themost potent
oxysterol ligand, 24, 25-EC, (Yang et al., 2006), desmosterol was
present in peritoneal macrophage foam cells at 20-fold higher
levels than the combined concentrations of 24,25-EC, 24S-OHC,
25-OHC, and 27-OHC, consistent with this sterol being the
dominant LXR ligand in this setting. Desmosterol was also the
dominant LXR ligand in cholesterol-loaded HMDMs and human
atherosclerotic lesions. These findings suggest that the molec-
ular and biochemical pathway for desmosterol production
identified in mouse peritoneal macrophage foam cells is likely
to be relevant to cholesterol homeostasis in human macro-
phages. It will therefore be of considerable interest to determine
whether the relative activity of this pathway is affected by natural
genetic variation and influences susceptibility to development of
atherosclerosis.
An important caveat in drawing conclusions from measure-
ments of cellular sterols and oxysterols is that their subcellular
compartmentalization is not known. The dramatic differences
in the amount of desmosterol released into the medium in
cholesterol-starved versus cholesterol-loaded macrophages
suggest that desmosterol is dedicated to cholesterol biosyn-
thesis under cholesterol-starved conditions but becomes acces-
sible to LXRs in cholesterol-loaded cells. This observation also
likely explains the increase in LXR target genes in macrophages
obtained from HCHF-fed WT mice despite relatively constant
levels of total cellular desmosterol and other LXR ligands
(Figure 2C). Defining the underlying mechanisms that regulate
access of desmosterol to LXRs will be an important question
for future investigation.
Because the cholesterol biosynthetic pathway is suppressed
in the setting of foam cell formation, the marked increase in
desmosterol (an intermediate in the cholesterol biosynthetic-Dependent and LXR-Independent Mechanisms
ies of indicated reporter constructs in RAW264.7 cells. *p < 0.01 versus KLA.
tylation (H3K9/14Ac) at promoter regions of desmosterol-repressedCxcl9 and
nomic region lacking H3K9/14Ac enrichment. *p < 0.05 versus KLA. n = 2.
, Cxcl10, IL1b, and iNos genes in peritoneal macrophages treated with either
input of LXR ChIP normalized to IgG control. *p < 0.05 versus control. n = 2.
9 andCxcl10 genes inWT and LXRa/bDKO (LXR DKO)macrophages. *p < 0.05
d n = 3 unless otherwise indicated.
umulation, leading to integration of cholesterol and fatty acid metabolism and
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pathway) was unexpected. We provide evidence that this
apparent paradox can be explained by the extreme sensitivity
of Dhcr24 to sterol-mediated suppression. DHCR24 is strategi-
cally placed as the first step of the Kandutsch-Russell pathway,
mediating conversion of lanosterol to 24,25-dihydrolanosterol,
and as the last step of the Bloch pathway, mediating conversion
of desmosterol to cholesterol. Our findings are consistent with
a model in which the relative activity of DHCR24 relative to
upstream enzymes in the cholesterol biosynthetic pathway is
preferentially inhibited by excess cholesterol. As a consequence,
flux through the cholesterol biosynthetic pathway is reduced but
not eliminated, leading to the accumulation of desmosterol, the
activation of LXRs, and further suppression of SREBP process-
ing via Insig/SCAP-dependent mechanisms (Figure 7E). This
coordinated regulatory response integrates both the feedfor-
ward and feedback arms of cholesterol homeostasis.
Roles of Desmosterol in Integration of Fatty Acid
Homeostasis
Although the target genes of SREBPs and LXRs involved in
cholesterol homeostasis are virtually mutually exclusive,
SREBPs and LXRs target a highly overlapping set of genes
involved in fatty acid biosynthesis. Although further studies will
be required to fully understand the functional interactions
between LXRs and SREBP1c at genes involved in fatty acid
metabolism in macrophages, our findings clearly indicate that
desmosterol is able to activate a subset of SREBP1 target genes,
exemplified by Scd1, Scd2, and Ascl4, despite inhibiting
SREBP1 binding to response elements in these genes. Each of
these genes is also a direct LXR target (Heinz et al., 2010), sug-
gesting that LXR activation is sufficient to drive their expression.
The present studies suggest that thisScd2 plays a primary role in
mediating increases in levels of 9Z-palmitoleic and oleic acids in
peritoneal macrophage foam cells, whereas the de novo biosyn-
thesis of saturated fatty acids is suppressed (Figure 7E). This
metabolic adaptation may be physiologically important in that
oleic acid is by far the major fatty acyl chain incorporated into
CE inmacrophages recovered from bothWT and LDLRKOmice.
Roles of Desmosterol in the Deactivated Macrophage
Phenotype
Perhaps the most unexpected finding of these studies was
the observation that macrophage foam cell formation is
associated with a deactivated, rather than activated, gene
expression profile. Numerous mechanisms are known that func-
tion to counter-regulate inflammatory responses within macro-
phages and other cell types. Among these, LXRs have been
demonstrated to suppress inflammatory-response genes in a
gene-specific manner through transrepression and other mech-
anisms (A-Gonzalez et al., 2009; Ghisletti et al., 2007; Joseph
et al., 2003). The present studies provide evidence that desmos-
terol contributes to the deactivated phenotype of peritoneal
macrophage foam cells in both an LXR-dependent and
LXR-independent manner (Figure 7E). It will be of interest to
definemechanisms responsible for LXR-independent repression
mechanisms.
The deactivated phenotype of peritoneal macrophage
foam cells implies that the acquisition of a proinflammatory150 Cell 151, 138–152, September 28, 2012 ª2012 Elsevier Inc.phenotype in the context of atherosclerotic lesions is dependent
on extrinsic proinflammatory stimuli within the artery wall. Such
stimuli would include inflammatory mediators derived from
endothelial cells and other cells in the artery wall (Charo and
Taubman, 2004; Glass and Witztum, 2001; Hansson et al.,
2006), uptake of cholesterol crystals (Duewell et al., 2010), and
exposure to debris from apoptotic and necrotic cells (Tabas,
2010). Intriguingly, not all lesion macrophages exhibit features
of classical activation, and there is evidence for considerable
phenotypic variation based on expression of cell-surface
markers (Johnson and Newby, 2009; Kadl et al., 2010; Tacke
et al., 2007). Specific macrophage foam cell subpopulations
that exhibit anti-inflammatory and atheroprotective features
have been identified. In particular, recent fluorescence-activated
cell sorting (FACS) analysis of lesion macrophage foam cell
subpopulations revealed that roughly 22% of these cells ex-
hibited features of ‘‘M2’’ or ‘‘alternatively activated’’ macro-
phages (Kadl et al., 2010).
The present findings also raise the question of whether the
pathway for generation of desmosterol or its intracellular
distribution are impaired in atherosclerotic lesion macrophages,
as this would be predicted to limit LXR-dependent cholesterol
efflux mechanisms, reduce conversion of palmitic acid to 9Z-
palmitoleic acid, and compromise other anti-inflammatory
effects of desmosterol. Although efforts to inhibit late stages of
the cholesterol biosynthetic pathway as a means of reducing
circulating cholesterol levels were curtailed by the complication
of cataract formation (Kirby, 1967), the present studies provide
evidence that the strategy of feedback suppression of Dhcr24
is used by macrophage foam cells to increase endogenous
desmosterol. This response in turn coordinately regulates the
functions of LXRs and SREBPs to enable appropriate homeo-
static responses to elevated levels of cholesterol and inhibits
inflammatory responses (Figure 7E). These findings therefore
provide impetus for further characterization and development
of synthetic desmosterol-like molecules as the basis of new ther-
apeutic interventions in cardiovascular disease.
EXPERIMENTAL PROCEDURES
Mice
Male WT C57BL6 or LDL receptor KO mice (Jackson Laboratory) were fed
a NCNF diet or a HCHF diet (Harlan Teklad, catalog # 96121 including 21%
milk fat and 1.25% cholesterol) for 12 weeks in an IACUC-approved animal
facility. Cells were harvested from the peritoneal cavity 4 days after intraperi-
toneal (i.p.) administration of 3% thioglycollate medium. Cells were immedi-
ately counted, aliquoted, pelleted, and sent for cDNA microarray analysis
and lipid measurement. For all other experiments, primary cells were isolated
from male 6- to 8-week-old C57BL6 mice (Charles River Laboratories).
Cell Culture
Mouse thioglycollate-elicited macrophages and bone marrow-derived macro-
phages were obtained and cultured as described previously (Heinz et al.,
2010). For various ligand treatments, cells were in Phenol-red free RPMI-
1640 (Invitrogen) supplemented with either 10% heat-inactivated FBS
(Hyclone) or 10% lipid-deficient FBS (Hyclone) for 24 hr before treatment,
then treated with either 1 mM GW3965, 0.25–20 mM desmosterol, or
0.3–30 mg/ml cholesterol for 12–24 hr. Fifty micromoles of mevalonate and
10 mM Mevastatin (Sigma) were added to media in desmosterol-response
experiments. For TLR repression studies, cells were cultured in medium con-
taining Phenol-red free RPMI-1640 (Invitrogen) with either heat-inactivated
FBS (Hyclone) or lipid-deficient FBS (Hyclone) for 24 hr, then pretreated
with either 20–30 mM desmosterol, 50 mg/ml cholesterol, 5 mM triparanol, or
50–100 mM 9Z-palmitoleic acid for 18 hr. Cells were stimulated with
Pam3CSK4 (300 ng/ml), polyI:C (50 ng/ml), LPS (100 ng/ml), TNF-a (30 ng/ml),
or KLA (100 ng/ml) for 6 hr. See Extended Experimental Procedures for addi-
tional details.
RNA Analysis
Total RNA was purified and analyzed by microarray and quantitative PCR as
previously described (Ghisletti et al., 2007). Either 1 ml of complementary
DNA (cDNA) or ChIP DNA was used for quantitative PCR with gene- or
locus-specific primers (primer sequences are indicated in Table S2). See
Extended Experimental Procedures for details of microarray analysis.
Lipid Measurements
Three separate experiments (biological replicates) and three technical
replicates were carried out, and to measure lipid species, liquid chromatog-
raphy-mass spectrometry (LC-MS) measurements were performed following
detailed protocols available online: http://www.lipidmaps.org/protocols/
index.html.
Raw lipid data are available at http://www.lipidmaps.org/data/results/foam/
foam.html.
ChIP
For ChIP of SREBP and LXR, 43 107macrophages were used per ChIP, which
was performed as described previously (Reed et al., 2008). For ChIP of p65
and H3K9/14Ac, 2 3 107 macrophages were used per ChIP, as described
previously (Heinz et al., 2010).
siRNA Knockdown
Thioglycollate-elicited macrophages were transfected with nonspecific (NS)
control or indicated SMARTpool siRNAs (Dharmacon) using Deliver X transfec-
tion reagent (Panomics) according to the manufacturer’s instructions. For
SREBP1 siRNA experiments, 48 hr post-transfection, cells were treated for
24 hr with vehicle (DMSO), 1 mM GW3965, or 10 mM desmosterol. For Scd2
and Dhcr24 siRNA experiments, 48 hr post-transfection, cells were treated
for 6 hr with vehicle (PBS) or 100 ng/ml KLA.
Reporter Gene Activity Assays
Transfections of RAW264.7 cells were performed as described previously
(Heinz et al., 2010). For KLA-response studies, at 48 hr post-transfection, cells
were treated with either 30 mM desmosterol or 100 mM 9Z-palmitoleic acid for
18 hr, followed by 100 ng/ml KLA for 8 hr. For activation experiments, cells
were treated with either 1 mMGW3965 or 10 mMdesmosterol for 24 hr. Relative
light units (RLU) were given as transformed ratio of firefly luciferase to
b-galactosidase.
Bioinformatics and Statistical Analysis
Microarray data were analyzed by GeneSpring GX 7.3.1. A small number of
genes specific to B1 cells in the peritoneal macrophage preparations were
eliminated from the list of statistically significant genes. Lipids with at least
five detectable values were tested by two-way ANOVA models to calculate
p values under the HCHF diet effect, LDLR KO effect, and their interaction.
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